| Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
|---|
| 05/28/2009 | US20090137530 Amine Compound and Use Thereof for Medical Purposes |
| 05/28/2009 | CA2706076A1 Novel cyclic hydrocarbon compounds for the treatment of diseases |
| 05/27/2009 | EP2062870A1 Oligoaniline compounds |
| 05/27/2009 | EP2061747A1 Method for producing an amine |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | CN101440041A Process for synthesizing mephenamine citrate salt |
| 05/27/2009 | CN100491351C Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/27/2009 | CN100491336C Novel derivatives of 3,3-diphenylpropylamines |
| 05/26/2009 | US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 05/26/2009 | US7538127 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation |
| 05/26/2009 | CA2464223C Quarternary ammonium compounds and their use as antimuscarinic agents |
| 05/22/2009 | WO2009062377A1 Resolution of 4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane |
| 05/22/2009 | WO2009034432A3 Novel compounds active as muscarinic receptor antagonists |
| 05/22/2009 | WO2007122579A3 Process for the preparation of 4-hydroxyalkylamino-2-nitro-anisoles |
| 05/20/2009 | EP2060582A1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 05/20/2009 | EP2060559A1 Process for the preparation of enantiomerically pure 3-hydroxy-3-arylpropylamines and their optical stereoisomers |
| 05/20/2009 | CN101437486A Personal care compositions containing quaternary ammonium trihydroxy substituted dipropyl ether |
| 05/20/2009 | CN101434552A Method for splitting 4,5- dimethoxy-1-(methyl amino methyl)-benzocyclobutane |
| 05/20/2009 | CN100488932C Diphenylether compound, its preparation and use |
| 05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
| 05/14/2009 | WO2009060282A2 Stilbene derivatives as pstat3/il-6 inhibitors |
| 05/14/2009 | WO2009009665A3 O-desmethylvenlafaxine |
| 05/14/2009 | US20090124809 Process for preparing acyclic hcv protease inhibitors |
| 05/14/2009 | US20090124808 Process for preparing acyclic hcv protease inhibitors |
| 05/14/2009 | US20090121617 Electronic devices made with electron transport and/or anti-quenching layers |
| 05/13/2009 | EP2057122A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor |
| 05/13/2009 | EP2057114A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 05/13/2009 | EP1753712B1 Amino-propanol derivatives |
| 05/13/2009 | CN101429132A Synthesis of 1,3-di(4-aminophenoxy)benzene |
| 05/13/2009 | CN100486980C Nitrogen-containing monodentate phosphines and their use in catalysis |
| 05/13/2009 | CN100486957C Process for producing amine derivatives |
| 05/12/2009 | US7531693 Lipids for transfection of nucleic acids |
| 05/12/2009 | US7531578 Compounds and methods for treating breast cancer and other diseases |
| 05/07/2009 | WO2009055869A1 Aryloxy amine compounds and their use as sodium channel modulators |
| 05/07/2009 | WO2009035535A3 Method of crystallizing carvedilol phosphate and the product thereof |
| 05/07/2009 | US20090117191 Controlled release tramadol formulations |
| 05/07/2009 | US20090114879 Additive for preserving the fluidity of fluids containing gas hydrates |
| 05/07/2009 | CA2704250A1 Aryloxy amine compounds and their use as sodium channel modulators |
| 05/06/2009 | CN101423479A Method for preparing substituted 1,1'-dinaphthalene-2,2'-diamines compounds |
| 05/05/2009 | CA2247675C Antifungal agents |
| 05/05/2009 | CA2233064C Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes |
| 04/30/2009 | WO2009054916A2 Oligomer conjugates of lidocaine and its derivatives |
| 04/30/2009 | WO2008046598A8 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 04/29/2009 | EP2053038A1 Aminoalcohol derivative and immunosuppressant containing the same as an active ingredient |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | CN101421227A Substantially pure o-desmethylvenlafaxine and processes for preparing it |
| 04/29/2009 | CN101417957A Synthesis method of dichloro tetrafluoroethoxy aniline |
| 04/29/2009 | CN101417956A Synthesis method of methoxamine hydrochloride |
| 04/29/2009 | CN100482639C N-bisaryl- and N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |
| 04/28/2009 | US7524990 Acylating a sulfonic acid with an alkyl- or arylacyl halide, anhydride or diphenylketene; reacting product with a dioxane, amination, and hydrolysis; 2-(2-t-butylaminoethoxy)ethanol from p-toluenesulfonic acid; acetyl chloride, acetic anhydride or diphenyl; 1,4-dioxane; and tert-butylamine |
| 04/28/2009 | US7524887 use of 2-(phenylalkyl)-substituted 2-amino-1,3-propanediols such as 2-amino-2-[2-(4-heptylphenyl)ethyl]-1,3-propanediol to treat chronic pain such as that associated with AIDs, chemotherapy, tumors, back pain; sphingosine-1-phosphate (SIP)-receptor agonists |
| 04/28/2009 | US7524886 L-(−)-moprolol L-(+)-tartrate |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | CA2259922C Calcium receptor active compounds |
| 04/23/2009 | WO2009052078A1 Ccr10 antagonists |
| 04/23/2009 | US20090105347 Thyronamine derivatives and analogs and methods of use thereof |
| 04/23/2009 | US20090105309 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation |
| 04/23/2009 | CA2702469A1 Ccr10 antagonists |
| 04/22/2009 | EP2049466A1 Butyl and butynyl benzyl amine compounds |
| 04/22/2009 | CN101412681A Method for preparing 3-(2-dimethyl aminomethyl-cyclohexyl)-phenol acetic ester hydrochloride |
| 04/22/2009 | CN101412680A Preparation of high-purity eptazocine intermediate |
| 04/22/2009 | CN100480232C L-(-)-moprolol l-(+)-tartrate |
| 04/22/2009 | CN100480231C Process for preparing phenethylamine derivatives |
| 04/16/2009 | WO2009048527A1 Substituted biphenyl gpr40 modulators |
| 04/16/2009 | WO2003082205A3 Compounds and methods |
| 04/15/2009 | EP2046726A1 Preparation of (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpentanamine |
| 04/15/2009 | EP2046724A1 Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 04/15/2009 | EP2003104A9 Reagent for organic synthesis and method of organic synthesis reaction with the reagent |
| 04/15/2009 | EP1136469B1 Organic electroluminescence element using an amine compound |
| 04/15/2009 | CN101407468A Novel method for synthesizing aclatonium napadisilate |
| 04/14/2009 | CA2338577C Pesticide formulations containing alkoxylated amine neutralized aromatic sulfonic acid surfactants |
| 04/09/2009 | WO2009043117A1 Novel aryl potassium channel blockers and uses thereof |
| 04/09/2009 | CA2701579A1 Novel aryl potassium channel blockers and uses thereof |
| 04/09/2009 | CA2701116A1 Alkoxy compounds for disease treatment |
| 04/08/2009 | EP2044045A2 A process for the preparation of substituted 2-acetylamino-alkoxyphenyl |
| 04/08/2009 | EP2043999A2 A process for the preparation of venlafaxine hydrochloride |
| 04/08/2009 | EP2043998A1 Method for producing an amine |
| 04/08/2009 | EP2043997A1 Method for producing an amine |
| 04/08/2009 | EP2043996A1 Method for producing an amine |
| 04/08/2009 | CN101405260A Amine derivatives |
| 04/08/2009 | CN101405257A Ethanolamine glyceryl ethers |
| 04/08/2009 | CN101405256A Process for preparing N,N-dimethylaminoethoxyethanol |
| 04/08/2009 | CN101405240A Reagent for organic synthesis and method of organic synthesis reaction with the reagent |
| 04/08/2009 | CN101402581A Method of preparing m-bromine oxethyl diphenylamine |
| 04/08/2009 | CN101402580A Method for preparing 2,2-bi[3-amino-4-(2,6-dinitryl-4-trifluoromethyl phenoxy phenyl] propane |
| 04/08/2009 | CN101402579A Method for preparing 3,3'-(1,2-dioxethyl)bidiphenylamine |
| 04/08/2009 | CN101402578A Method of preparing m-oxethyl diphenylamine |
| 04/08/2009 | CN100475775C Highly pure bases of 3,3-diphenyl propylamine monoesters |
| 04/08/2009 | CN100475772C Tech. of preparing amino benz methyl-phenoxide by nitro methyl-phenoxide mixture catalyzing hydrogenation |
| 04/07/2009 | US7514557 Hepatitis C; preparing 8-bromo-7-alkoxyquinolines 2-substituted with a hetercyclic ring having an amine, carbamate, amine or urea group an 4-substituted with a 3-prolineoxy- group or derivative; intermediates |
| 04/07/2009 | US7514473 Calcium receptor antagonist; (E)-3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-phenyl}-acrylic acid hydrochloride; bone disorders; hypoparathyroidism, osteosarcoma, periodontal disease, fracture healing, arthritis, Paget's disease, humoral hypercalcemia, osteoporosis |
| 04/07/2009 | CA2390116C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/07/2009 | CA2343962C Process for preparing carboxylic acids |
| 04/07/2009 | CA2276278C Amine compounds, their production and use |
| 04/02/2009 | WO2009042013A1 Process for the synthesis of e1 activating enzyme inhibitors |
| 04/02/2009 | WO2009041000A1 Aliphatic amine alkylene oxide adduct |
| 04/02/2009 | US20090088464 Merged ion channel modulating compounds and Uses Thereof |
| 04/02/2009 | CA2695193A1 Process for the synthesis of e1 activating enzyme inhibitors |
| 04/01/2009 | EP2042480A1 Aminoindan derivative or salt thereof |